Pages that link to "Q73467050"
Jump to navigation
Jump to search
The following pages link to Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C (Q73467050):
Displaying 50 items.
- The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years (Q24634716) (← links)
- Review of patient-reported outcome measures in chronic hepatitis C (Q26828825) (← links)
- Activity and Life After Survival of a Cardiac Arrest (ALASCA) and the effectiveness of an early intervention service: design of a randomised controlled trial (Q33295232) (← links)
- Validation of the Fatigue Severity Scale in chronic hepatitis C. (Q33890671) (← links)
- Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients (Q33917437) (← links)
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study (Q33956796) (← links)
- Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases. (Q34012572) (← links)
- Fatigue in primary biliary cirrhosis (Q34114608) (← links)
- Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection (Q34174207) (← links)
- The Relationship of Chronological Age, Age at Injury, and Duration of Injury to Employment Status in Individuals with Spinal Cord Injury (Q34548753) (← links)
- Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome. (Q35020947) (← links)
- Fatigue in multiple sclerosis: definition, pathophysiology and treatment (Q35094640) (← links)
- The Course of Fatigue during the First 18 Months after First-Ever Stroke: A Longitudinal Study (Q35295343) (← links)
- Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals (Q35588145) (← links)
- A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. (Q35619107) (← links)
- The assessment of fatigue: a practical guide for clinicians and researchers. (Q35689136) (← links)
- Peginterferon alfa-2a: a review of approved and investigational uses (Q35874153) (← links)
- Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis (Q35954503) (← links)
- Fatigue complicating chronic liver disease (Q35956377) (← links)
- Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. (Q36335752) (← links)
- Factors Associated with Fatigue in Korean Gastric Cancer Survivors (Q36339016) (← links)
- Fatigue and related factors after liver transplantation (Q36383860) (← links)
- Measuring fatigue in persons with spinal cord injury (Q36677684) (← links)
- Clinical correlates of fatigue in spinal cord injury (Q36779404) (← links)
- The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia (Q36916690) (← links)
- Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory (Q36990303) (← links)
- Validity and reliability of the FSS in Greek MS patients (Q37009256) (← links)
- Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson's disease patients (Q37191452) (← links)
- Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study (Q37327979) (← links)
- Maintenance of effects of a home-based physical activity program among breast cancer survivors. (Q37355111) (← links)
- Fatigue: an important feature of late-onset Pompe disease (Q37425960) (← links)
- Wavelet coherence analysis of cerebral oxygenation signals measured by near-infrared spectroscopy in sailors: an exploratory, experimental study (Q37454090) (← links)
- Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer (Q37477034) (← links)
- Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. (Q37668003) (← links)
- Fatigue in advanced kidney disease (Q38201591) (← links)
- Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis (Q38948929) (← links)
- Links between private habits, psychological stress and brain cancer: a case-control pilot study in France. (Q39950268) (← links)
- Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin (Q40431770) (← links)
- Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study (Q40821688) (← links)
- Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C. (Q40924774) (← links)
- Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial (Q41613250) (← links)
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial (Q42211649) (← links)
- Psychometric properties of the Fatigue Severity Scale—Rasch analyses of individual responses in a Norwegian stroke cohort (Q43800524) (← links)
- Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale. (Q43815423) (← links)
- Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. (Q44471012) (← links)
- Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia (Q44814444) (← links)
- The role of attachment style and depression in patients with hepatitis C. (Q46345046) (← links)
- Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients (Q46536417) (← links)
- Methodological issues and the measurement of fatigue in primary biliary cirrhosis (Q46552210) (← links)
- Pilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms (Q47686010) (← links)